Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

The combination therapy was effective and well-tolerated, especially in young patients.

Tacrolimus can cause hair loss in kidney transplant patients.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Single-dose parenteral iron is safe and effective for children with inflammatory bowel disease and iron-deficiency anemia.

Azathioprine may be an effective treatment for severe hair loss.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

FMT for ulcerative colitis may also help with weight loss, hair loss, arthritis, and allergies.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Anti-CD19 therapy may help treat SLE and NMOSD.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Leflunomide can cause skin ulcers, and stopping it can lead to healing.

Skin issues and diarrhea can signal ulcerative colitis, needing further checks.

Monitor methotrexate side effects, research cannabis treatments, and use mycophenolate mofetil for lupus nephritis.

A group has developed therapies that show promise for treating cancer and various other conditions.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Imuvert can prevent some chemotherapy-induced hair loss.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.